Rami S. Komrokji, M.D. Moffitt Cancer Center
Dr. Komrokji is the Clinical Director of the Malignant Hematology Department and the lead clinical investigator for the Myelodysplastic Syndrome Program at the Moffitt Cancer Center, Tampa, Florida.
He is a senior member of the Malignant Hematology and Experimental Therapeutics Program at the Moffitt Cancer Center, and Professor in Medicine & Oncologic Sciences at the College of Medicine, at the University of South Florida in Tampa, Florida.
After earning a medical degree in 1996 from the Jordan University School of Medicine, Dr. Komrokji completed an internship and residency at Case Western University, St. Vincent Program. He then completed a fellowship at Strong Memorial Hospital, University of Rochester, in hematology/oncology and hematopoietic stem cell transplantation.
Dr. Komrokji is a member of the American Society of Hematology, American Society of Clinical Oncology. He was President of the American VA Hematology/Oncology Association.
He has authored or co-authored more than 100 peer-reviewed manuscripts, 20 book chapters, and more than 200 abstracts in hematologic malignancies. He serves as member on the myelodysplastic syndrome panel of the National Comprehensive Cancer Network. He was member of the editorial board for Journal of Clinical Oncology. He is peer reviewer for several medical journals including Blood Journal, JCO and Leukemia Journal.
Dr. Komrokji’s research interests are in phase 1 and 2 clinical trials, and in the outcome research in hematologic malignancies with focus on myeloid neoplasms. His clinical interests are myelodysplastic syndrome, acute leukemias, and myeloproliferative neoplasms.